Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system

被引:173
作者
Huang, Yangxin
Liu, Dacheng
Wu, Hulin
机构
[1] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
[2] Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL 33612 USA
关键词
antiretroviral drug therapy; Bayesian mixed-effects models; drug exposures; drug resistance; HIV dynamics; MCMC; parameter estimation;
D O I
10.1111/j.1541-0420.2005.00447.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV dynamics studies have significantly contributed to the understanding of HIV infection and antiviral treatment strategies. But most studies are limited to short-term viral dynamics due to the difficulty of establishing a relationship of antiviral response with multiple treatment factors such as drug exposure and drug susceptibility during long-term treatment. In this article, a mechanism-based dynamic model is proposed for characterizing long-term viral dynamics with antiretroviral therapy, described by a set of nonlinear differential equations without closed-form solutions. In this model we directly incorporate drug concentration, adherence, and drug susceptibility into a function of treatment efficacy, defined as an inhibition rate of virus replication. We investigate a Bayesian approach under the framework of hierarchical Bayesian (mixed-effects) models for estimating unknown dynamic parameters. In particular, interest focuses on estimating individual dynamic parameters. The proposed methods not only help to alleviate the difficulty in parameter identifiability, but also flexibly deal with sparse and unbalanced longitudinal data from individual subjects. For illustration purposes, we present one simulation example to implement the proposed approach and apply the methodology to a data set from an AIDS clinical trial. The basic concept of the longitudinal HIV dynamic systems and the proposed methodologies are generally applicable to any other biomedical dynamic systems.
引用
收藏
页码:413 / 423
页数:11
相关论文
共 33 条
  • [1] Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals
    Acosta, EP
    Wu, HL
    Hammer, SM
    Yu, S
    Kuritzkes, DR
    Walawander, A
    Eron, JJ
    Fichtenbaum, CJ
    Pettinelli, C
    Neath, D
    Ferguson, E
    Saah, AJ
    Gerber, JG
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (03) : 1358 - 1366
  • [2] Global identifiability of nonlinear models of biological systems
    Audoly, S
    Bellu, G
    D'Angiò, L
    Saccomani, MP
    Cobelli, C
    [J]. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2001, 48 (01) : 55 - 65
  • [3] COMPLIANCE IN CLINICAL-TRIALS
    BESCH, CL
    [J]. AIDS, 1995, 9 (01) : 1 - 10
  • [4] Carlin B. P., 2001, BAYES EMPIRICAL BAYE
  • [5] Davidian M., 1995, NONLINEAR MODELS REP
  • [6] Ding A A, 2001, Biostatistics, V2, P13, DOI 10.1093/biostatistics/2.1.13
  • [7] Identifiability, improper priors, and Gibbs sampling for generalized linear models
    Gelfand, AE
    Sahu, K
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (445) : 247 - 253
  • [8] SAMPLING-BASED APPROACHES TO CALCULATING MARGINAL DENSITIES
    GELFAND, AE
    SMITH, AFM
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1990, 85 (410) : 398 - 409
  • [9] ILLUSTRATION OF BAYESIAN-INFERENCE IN NORMAL DATA MODELS USING GIBBS SAMPLING
    GELFAND, AE
    HILLS, SE
    RACINEPOON, A
    SMITH, AFM
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1990, 85 (412) : 972 - 985
  • [10] GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727